Cipvision Nafibest 0.1 Ophthalmic Suspension provides an advanced, tissue-targeted topical anti-inflammatory therapy meticulously designed for the prevention and management of intraocular pain and inflammation following cataract surgery. By employing a unique biochemical prodrug structure, this formulation achieves exceptional corneal penetration while minimizing surface side effects, ensuring deep-seated therapeutic stabilization across both anterior and posterior segments of the eye where standard topical NSAIDs often show restricted efficacy.
Unlike conventional topical anti-inflammatory drops, Nepafenac is molecules-engineered as an inactive prodrug. Upon administration, it effortlessly passes through the surface layers of the cornea. Once inside the intraocular fluids and vascular tissues, target hydrolase enzymes smoothly convert nepafenac into its highly active metabolite, amfenac. Amfenac operates as a powerful inhibitor of cyclooxygenase ($COX-1$ and $COX-2$) enzyme networks, successfully blocking the biosynthesizing layout of inflammatory prostaglandins responsible for triggering post-surgical ocular pain, miosis, internal tissue swelling, and vascular leakage. This targeted action effectively protects the delicate macular tissue at the back of the eye from secondary cystoid macular edema (CME), facilitating faster visual recovery milestones.
Key Benefits
-
Advanced Prodrug Design: Maximizes active internal drop penetration by transforming into amfenac only after passing deeply into the ocular structure.
-
Rapid Post-Surgical Relief: Directly reduces the sharp grid of pain, stinging sensations, and foreign body discomfort after lens implants.
-
Controls Ocular Swelling: Effectively minimizes standard post-operative intraocular tissue swelling and redness.
-
Macular Protection Core: Helps shield the retina’s central filtering zone from fluid accumulation tracking issues, particularly beneficial for diabetic cataract cases.
-
Trusted Quality: Formulated under the strict sterile manufacturing parameters of Steris Healthcare, ensuring accurate droplet volume distribution and absolute bio-safety baselines.
Directions for Use
-
Use exactly as directed by your ophthalmologist or eye care surgeon.
-
How to Administer: Tilt your head back slightly, pull down your lower eyelid to form a small pocket, and squeeze exactly 1 drop of the suspension into the eye gap layout.
-
Crucial Step: Shake the bottle vigorously before every single use to distribute the suspension matrix evenly.
-
Close your eyes softly for 1 to 2 minutes and press gently on the inner corner of your eye (near the nose) to prevent the solution from draining into your throat.
-
If you wear contact lenses: Remove them before using Nafibest 0.1. Wait at least 15 minutes post-application before reinserting, or follow your surgeon’s custom postoperative layout rules.
-
Never let the dropper tip touch your eye, fingers, or any exterior surface to prevent bacterial contamination.
Safety & Precautions
-
Do not modify your drop frequency or halt usage suddenly without surgical clearance, as uncontrolled post-surgical inflammation rebound can occur.
-
May cause mild temporary blurred vision or brief stinging immediately following application. Avoid driving or navigating staircases until your sight becomes entirely clear.
-
Inform your specialist if you have a known history of bleeding tendencies, dry eye syndrome, or repeat corneal surgeries before initializing daily schedules.
-
If using multiple eye drop products, maintain a strict minimum gap of 5 to 10 minutes between different drop instillations to prevent washing out active medication lines.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 25°C. Do not freeze.
-
Protect from direct sunlight, ambient heat sources, and room humidity setups.
-
Crucial Discard Rule: Discard the bottle and any remaining liquid exactly 4 weeks after first opening the sterile seal. Mark the date of opening clearly on the box layout.
